The largest database of trusted experimental protocols

Insulin

Insulin is a peptide hormone produced by the pancreatic beta cells that regulates blood sugar levels.
It facilitates the uptake of glucose by cells, promoting its storage as glycogen and fat.
Insulin also plays a role in protein and lipid metabolism.
Disruptions in insulin production or signaling can lead to conditions like diabetes mellitus.
Researchers use a variety of insulin-related products and procedures to investigate the underlying mechanisms and potential therapies for insulin-related disorders.
PubCompare.ai can help optimize your insulin research by locating the best protocols from literature, pre-prints, and patents, enhancing reproducibility and accuracy to ensure you find the most effective insulin-related products and procedures.
Explore PubComapre.ai today and take your insulin research to the next level.

Most cited protocols related to «Insulin»

We obtained summary statistics (association P-values and Z-scores for direction of effect or allelic effects and standard errors) for lead T2D SNPs in GWAS meta-analyses of metabolic traits in European descent populations. Summary statistics were aligned to the T2D risk allele from the combined meta-analysis. We obtained summary statistics for lead SNPs in all newly discovered and established loci for glycemic traits in non-diabetic individuals from the MAGIC Investigators5 (link),34 . For fasting glucose and fasting insulin, the meta-analysis comprised up to 133,010 individuals, genotyped with GWAS arrays and imputed on up to ~2.5 million SNPs, or genotyped with Metabochip. We also considered surrogate estimates of beta-cell function (HOMA-B) and insulin resistance (HOMA-IR) derived by homeostasis model assessment in up to 38,238 individuals (from GWAS meta-analysis only since these traits were not investigated in the enlarged MAGIC Metabochip study). We obtained summary statistics for lead SNPs in the newly discovered T2D loci (also including GRB14 and HMG20A) for BMI in up to 119,600 individuals from the GIANT Consortium15 (link). To eliminate potential bias in BMI allelic effect estimates at T2D susceptibility loci54 (link), we restricted our attention to meta-analysis of population-based studies not ascertained for disease status for ~2.8 million directly genotyped and/or imputed SNPs. We obtained summary statistics for the same SNPs for plasma lipid concentrations from the Global Lipids Genetics Consortium16 (link). This meta-analysis comprised ~2.6 million directly genotyped and/or imputed SNPs assessed for association to plasma concentrations of: total cholesterol (up to 100,184 individuals); LDL (up to 95,454 individuals); HDL (up to 99,900 individuals); and triglycerides (up to 96,598 individuals).
We also examined T2D association summary statistics at lead SNPs for 37 established T1D susceptibility loci. For each of these SNPs, we reported the allelic OR (aligned to the T2D risk-allele) and P-values in: (i) our Stage 1 T2D meta-analysis; and (ii) a GWAS meta-analysis of 7,514 T1D cases and 9,045 population controls from European descent populations from the Type 1 Diabetes Genetics Consortium35 (link).
Publication 2012
Alleles Attention Cholesterol Diabetes Mellitus, Insulin-Dependent Europeans Genome-Wide Association Study Gigantism Glucose GRB14 protein, human Homeostasis Insulin Insulin Resistance Lipids Physiology, Cell Plasma Single Nucleotide Polymorphism Susceptibility, Disease Triglycerides
Besides a clinical and laboratory evaluation, each subject underwent a liver ultrasonography, an anthropometric assessment and a 7-day diary of food intake (7DD) [1 (link)]. HBsAg and anti-HCV antibodies were assessed and subjects with anti-HCV antibodies underwent an HCV-RNA assessment to confirm HCV infection [1 (link),14 (link)]. ALT, aspartate transaminase (AST), GGT, glucose, triglycerides and cholesterol were measured by standard laboratory methods after 8-hr fasting. Insulin was measured by radio-immuno-assay (ADVIA Insulin Ready Pack 100, Bayer Diagnostics, Milan, Italy), with intra- and inter-assay coefficients of variation < 5%. FL was diagnosed by the same operator at ultrasonography [6 (link)]. Weight, stature, circumferences (waist and hip) and skinfolds (triceps, biceps, subscapular and suprailiac) were measured by two trained dietitians who had been standardized before and during the study according to standard procedures [15 ]. Body mass index (BMI) was calculated as weight (kg)/stature (m)2 and the sum of 4 skinfolds by summing triceps, biceps, subscapular and suprailiac skinfolds [16 (link),17 (link)]. The 7DD was administered to the subjects by two trained dietitians, who discussed it with the subject when she/he returned it one week later [18 (link)]. To avoid the confounding effect of seasonality on food intake, the 7DD diary was administered to a similar number of patients with and without SLD each month [19 ]. Mean daily ethanol intake was calculated as the mean value of ethanol intake as assessed by the 7DD [20 ]. The study protocol was approved and supervised by the Scientific Committee of the Fondo per lo Studio delle Malattie del Fegato (Trieste, Italy), and all subjects gave their written informed consent to participate.
Full text: Click here
Publication 2006
Aspartate Transaminase Biological Assay Body Height Cholesterol Dietitian Eating Ethanol Glucose Hepatitis B Surface Antigens Hepatitis C Hepatitis C Antibodies Index, Body Mass Insulin Liver Patients Radioimmunoassay Triglycerides Ultrasonography
Continuous variables are given as medians and interquartile ranges (IQR) because of skewed distributions. Comparisons of continuous variables between subjects with and without FL were performed with the Mann-Whitney test and those of nominal variables with the Fisher's exact test. To identify candidate predictors of FL, we performed a stepwise logistic regression analysis on 1000 bootstrap samples of 496 subjects (probability to enter = 0.05 and probability to remove = 0.1) [21 (link)]. All variables besides gender were evaluated as continuous predictors. Linearity of logits was ascertained using the Box-Tidwell procedure [22 (link)]. To obtain a linear logit, we transformed age using the coefficient suggested by the Box-Tidwell procedure [(age/10) 4.9255] and ALT, AST, GGT, insulin and triglycerides using natural logarithms (loge). The logits of the other predictors (BMI, waist circumference, glucose, cholesterol, ethanol and the sum of 4 skinfolds) were linear.
Candidate predictors identified at bootstrap analysis were evaluated using three stepwise logistic models before obtaining a final prediction model (probability to enter = 0.01 and probability to remove = 0.02; these more stringent levels were used to protect against type I errors). The goodness of fit of the models was evaluated using the Hosmer-Lemeshow statistic and their accuracy was assessed by calculating the non-parametric area (AUC) under the receiver-operating curve (ROC) with 95% confidence intervals (95%CI) [23 ,24 ]. The standard errors of the regression coefficients of the final model were calculated using 1000 bootstrap samples of 496 subjects. The probabilities obtained from the final model were multiplied by 100 to obtain the fatty liver index (FLI). The sensitivity (SN), specificity (SP), positive likelihood ratio (LR+) and negative likelihood ratio (LR-) of 10-value intervals of FLI were calculated [23 ]. Statistical analysis was performed using STATA 9.2 (StataCorp, College Station, Texas, USA).
Full text: Click here
Publication 2006
Cholesterol Ethanol Fatty Liver Gender Glucose Hypersensitivity Insulin Triglycerides Waist Circumference
The Metabochip was designed by representatives of the Body Fat Percentage [9] (link), CARDIoGRAM (coronary artery disease and myocardial infarction) [10] (link), DIAGRAM (type 2 diabetes) [11] (link), GIANT (anthropometric traits) [3] (link), [12] (link), [13] (link), Global Lipids Genetics (lipids) [4] (link), HaemGen (hematological measures) [14] (link), ICBP (blood pressure) [15] (link), MAGIC (glucose and insulin) [16] (link)–[18] (link), and QT-IGC (QT interval) [19] (link), [20] (link) GWAS meta-analysis consortia. The array is comprised of SNPs selected across two tiers of traits (Table 1). Tier 1 is comprised of eleven traits deemed to be of primary interest: type 2 diabetes (T2D), fasting glucose, coronary artery disease and myocardial infarction (CAD/MI), low density lipoprotein (LDL) cholesterol, high density lipoprotein (HDL) cholesterol, triglycerides, body mass index (BMI), systolic and diastolic blood pressure, QT interval, and waist-to-hip ratio adjusted for BMI (WHR). Tier 2 is comprised of twelve traits of secondary interest: fasting insulin, 2-hour glucose, glycated hemoglobin (HbA1c), T2D age of diagnosis, early onset T2D (diagnosis age<45 years), waist circumference adjusted for BMI, height, body fat percentage, total cholesterol, platelet count, mean platelet volume, and white blood cell count.
We included three design classes of SNPs on the Metabochip (Table 2):
In total, 217,695 SNPs were chosen for the array (Table 2). 20,970 SNPs (9.6%) failed during the assay manufacturing process, resulting in 196,725 SNPs available for genotyping. A summary file annotating each Metabochip SNP with ascertainment criteria, SNP assay, a list of unintended duplicate SNPs (Supplementary Table S4), and reference strand orientation for alleles is provided at http://www.sph.umich.edu/csg/kang/MetaboChip/.
Full text: Click here
Publication 2012
ADCAD1 Alleles Biological Assay Blood Pressure Body Fat Cholesterol Diabetes Mellitus, Non-Insulin-Dependent Diagnosis Genome-Wide Association Study Gigantism Glucose Hemoglobin, Glycosylated High Density Lipoprotein Cholesterol Index, Body Mass Insulin Leukocyte Count Lipids Low-Density Lipoproteins Platelet Counts, Blood Pressure, Diastolic Single Nucleotide Polymorphism Systole Triglycerides Volumes, Mean Platelet Waist-Hip Ratio Waist Circumference
To determine whether the identified loci were also associated with any of 22 cardio-metabolic traits, we obtained association data from meta-analysis consortia DIAGRAM (T2D)58 (link), CARDIoGRAM-C4D (CAD)59 (link), ICBP (SBP, DBP)60 (link), GIANT (BMI, height)36 ,37 , GLGC (HDL, LDL, and TG)61 (link), MAGIC (fasting glucose, fasting insulin, fasting insulin adjusted for BMI, and two-hour glucose)62 (link)-64 (link), ADIPOGen (BMI-adjusted adiponectin)65 (link), CKDgen (urine albumin-to-creatinine ratio (UACR), estimated glomerular filtration rate (eGFR), and overall CKD)66 (link),67 (link), ReproGen (age at menarche, age at menopause)68 (link),69 (link), and GEFOS (bone mineral density)70 (link); others provided association data for IgA nephropathy71 (link) (also Kiryluk K, Choi M, Lifton RP, Gharavi AG, unpublished data) and for endometriosis (stage B cases only)72 (link). Proxies (r2>0.80 in CEU) were used when an index SNP was unavailable.
We also searched the National Human Genome Research Institute (NHGRI) GWAS Catalog for previous SNP-trait associations near our lead SNPs73 (link). We supplemented the catalog with additional genome-wide significant SNP-trait associations from the literature13 (link),70 (link),74 (link)-80 (link). We used PLINK to identify SNPs within 500 kb of lead SNPs using 1000 Genomes Project Pilot I genotype data and LD (r2) values from CEU81 (link),82 (link); for rs7759742, HapMap release 22 CEU data81 (link),83 (link) were used. All SNPs within the specified regions were compared with the NHGRI GWAS Catalog16 .
Publication 2014
ADIPOQ protein, human Albumins Bone Density Creatinine Endometriosis Genome Genome-Wide Association Study Genotype Gigantism Glomerular Filtration Rate Glucose HapMap Insulin Menarche Menopause Single Nucleotide Polymorphism Urine

Most recents protocols related to «Insulin»

Example 3

Human primary sebocytes (Zenbio, RTP, NC) were plated at confluence on 96 well Scintiplates and allowed to adhere overnight. Cells were treated with the SCD1 inhibitor Compound A prepared in media containing the LXR agonist and insulin and cultured overnight. The DGAT inhibitor A922500 (2 μM) was included as a positive control. The following day 14C-acetate was added to each well and the plate was gently mixed. Cells were placed in the incubator at 37° C. for 4 hours total. After 2 hours of incubation the Cell Titer Blue (CTB) assay was started, 10 μl of CTB reagent was added to each well and incubated for the remaining 2 hours at 37° C. Following the 4 hour incubation, the RFU was determined using the SpectraMax Gemini EM under the following parameters: 560ex/590em with a 570 cutoff, top read. The medium was removed and cells were washed 3× with PBS. All of the PBS was removed from the wells and the plates were allowed to air dry. The plate was read in the MicroBeta TriLux counter and data was analyzed as CPM and normalized to CTB readout. Data is shown in FIG. 2.

Full text: Click here
Patent 2024
Acetate Biological Assay Cells Homo sapiens Insulin N,N,N-triethyl-11-(4-methyl-2-oxo-2H-chromen-7-yloxy)-11-oxoundecan-1-aminium bromide Psychological Inhibition

Example 10

Spray-dried disodium FDKP/insulin powder as described in Examples 6 or 7 is packed into hard gelatin capsules. The capsules can contain approximately 50-100 mg of powder. The FDKP salt/insulin powders prepared in Examples 6 and 7 were 25% insulin by weight and insulin activity was about 26 units/mg. Thus, 50 mg would be on the order of 1300 units, significantly larger than a typical dose. About 2-30 mg of the FDKP salt/insulin powder is mixed with methyl cellulose (other bulking agents are well known in the art) to make up the balance of the desired mass.

Full text: Click here
Patent 2024
3,6-bis(N-fumaryl-N(n-butyl)amino)-2,5-diketopiperazine Capsule Gelatins Insulin Methylcellulose Oral Spray Powder SALL2 protein, human Sodium Chloride
Not available on PMC !

Example 6

To investigate the effect of insulin on CNS signaling, LA1-55 neuroblastoma cells were treated for 1 hour with 200 nM of insulin. The results are shown in FIG. 6. The results can demonstrate that insulin treatment can increase Akt activity, Akt-dependent GSK3P and mTOR phosphorylation, aPKC activity and Aβ1-40/42 peptide levels in neuronal cells.

Additionally, activation of CNS p-Ser-473-Akt, p-Thr-55/560-aPKC, BACE1, aPKC activity and Aβ1-40/42 levels, by insulin in various mouse models was evaluated. Results are shown in FIGS. 5A-5B, FIGS. 7-8C.

Full text: Click here
Patent 2024
BACE1 protein, human Cells Figs FRAP1 protein, human inhibitors Insulin Mus Neuroblastoma Neurodegenerative Disorders Neurons Peptides Phosphorylation
Not available on PMC !

Example 11

Capsules containing the FDKP salt and insulin are taken before a meal. The exact dosage is patient-specific, but generally on the order of approximately 10-150 units of insulin is administered per dose. The subsequent insulin absorption attenuates post-prandial blood glucose excursions. This oral insulin formulation is used to replace pre-meal insulin injections in patients with diabetes. Additionally, insulin absorbed through the gastrointestinal tract mimics endogenous insulin secretion. Endogenous insulin is secreted by the pancreas into the portal circulation. Insulin absorbed following oral administration also goes directly to the portal circulation. Thus, the oral route of insulin administration delivers insulin to its site of action in the liver, offering the potential to control glucose levels while limiting systemic exposure to insulin. Oral insulin delivery using a combination of insulin and the diacid form of FDKP is hindered by the poor solubility of the FDKP diacid in the low pH environment of the gastrointestinal tract. The FDKP salts, however, provide a local buffering effect that facilitates their dissolution in low pH.

Full text: Click here
Patent 2024
3,6-bis(N-fumaryl-N(n-butyl)amino)-2,5-diketopiperazine Administration, Oral Blood Glucose Capsule Diabetes Mellitus Gastrointestinal Tract Glucose Insulin Insulin Secretion Liver Obstetric Delivery Pancreas Patients Salts Sodium Chloride
Not available on PMC !

Example 9

These include any type of insulin pumps, chemotherapy pumps, pain killers-administration pump, intrathecal pumps, diuretic pumps, and alike, which work via a closed-loop integrating into their operating systems methods or algorithms which incorporate personalized-variability pattern(s).

Managing patients with severe insulin resistance is challenging because it is difficult to achieve good glycemic control using conventional treatment approaches. The algorithm identifies patterns of variability in glucose levels in each subject and implement them into a treatment schedule of the basal-bolus insulin pump which alters the regularity of the dosages and intervals between dosages, as a method for alleviating resistance and reducing overall insulin requirement. For pain-killer pumps, the goal is reducing the amount of painkillers administered to the patient by implementing inherent variability patterns into the treatment algorithm.

Full text: Click here
Patent 2024
Analgesics Diuretics Glucose Glycemic Control Insulin Insulin Resistance Management, Pain Pain Patients Pharmacotherapy Precision Medicine Treatment Protocols

Top products related to «Insulin»

Sourced in United States, Germany, United Kingdom, China, France, Canada, Italy, Sao Tome and Principe, Japan, Switzerland, Macao, Israel, Australia, Spain, Austria, Sweden, Poland, Denmark, New Zealand, Belgium, Portugal, Ireland, Netherlands, Brazil, Colombia, India, Morocco, Argentina
Insulin is a lab equipment product designed to measure and analyze insulin levels. It provides accurate and reliable results for research and diagnostic purposes.
Sourced in United States, China, United Kingdom, Germany, Australia, Japan, Canada, Italy, France, Switzerland, New Zealand, Brazil, Belgium, India, Spain, Israel, Austria, Poland, Ireland, Sweden, Macao, Netherlands, Denmark, Cameroon, Singapore, Portugal, Argentina, Holy See (Vatican City State), Morocco, Uruguay, Mexico, Thailand, Sao Tome and Principe, Hungary, Panama, Hong Kong, Norway, United Arab Emirates, Czechia, Russian Federation, Chile, Moldova, Republic of, Gabon, Palestine, State of, Saudi Arabia, Senegal
Fetal Bovine Serum (FBS) is a cell culture supplement derived from the blood of bovine fetuses. FBS provides a source of proteins, growth factors, and other components that support the growth and maintenance of various cell types in in vitro cell culture applications.
Sourced in United States, Germany, United Kingdom, China, Japan, Italy, Sao Tome and Principe, Macao, France, Australia, Switzerland, Canada, Denmark, Spain, Israel, Belgium, Ireland, Morocco, Brazil, Netherlands, Sweden, New Zealand, Austria, Czechia, Senegal, Poland, India, Portugal
Dexamethasone is a synthetic glucocorticoid medication used in a variety of medical applications. It is primarily used as an anti-inflammatory and immunosuppressant agent.
Sourced in United States, Germany, United Kingdom, France, China, Italy, Canada, Macao, Japan, Israel, Switzerland, Australia, Sao Tome and Principe, Spain, Austria, Portugal, Belgium, Denmark, Sweden, Argentina, Brazil, Poland, New Zealand
Hydrocortisone is a laboratory-grade reagent used in various research and analytical applications. It is a synthetic corticosteroid compound with anti-inflammatory and immunosuppressant properties. Hydrocortisone is commonly utilized as a standard or reference material in analytical procedures, such as assays and chromatographic techniques, to quantify and identify related compounds.
Sourced in United States, Germany, United Kingdom, China, Canada, France, Japan, Australia, Switzerland, Israel, Italy, Belgium, Austria, Spain, Gabon, Ireland, New Zealand, Sweden, Netherlands, Denmark, Brazil, Macao, India, Singapore, Poland, Argentina, Cameroon, Uruguay, Morocco, Panama, Colombia, Holy See (Vatican City State), Hungary, Norway, Portugal, Mexico, Thailand, Palestine, State of, Finland, Moldova, Republic of, Jamaica, Czechia
Penicillin/streptomycin is a commonly used antibiotic solution for cell culture applications. It contains a combination of penicillin and streptomycin, which are broad-spectrum antibiotics that inhibit the growth of both Gram-positive and Gram-negative bacteria.
Sourced in United States, China, United Kingdom, Germany, France, Australia, Canada, Japan, Italy, Switzerland, Belgium, Austria, Spain, Israel, New Zealand, Ireland, Denmark, India, Poland, Sweden, Argentina, Netherlands, Brazil, Macao, Singapore, Sao Tome and Principe, Cameroon, Hong Kong, Portugal, Morocco, Hungary, Finland, Puerto Rico, Holy See (Vatican City State), Gabon, Bulgaria, Norway, Jamaica
DMEM (Dulbecco's Modified Eagle's Medium) is a cell culture medium formulated to support the growth and maintenance of a variety of cell types, including mammalian cells. It provides essential nutrients, amino acids, vitamins, and other components necessary for cell proliferation and survival in an in vitro environment.
Sourced in United States, United Kingdom, Germany, China, France, Japan, Canada, Australia, Italy, Switzerland, Belgium, New Zealand, Spain, Denmark, Israel, Macao, Ireland, Netherlands, Austria, Hungary, Holy See (Vatican City State), Sweden, Brazil, Argentina, India, Poland, Morocco, Czechia
DMEM/F12 is a cell culture medium developed by Thermo Fisher Scientific. It is a balanced salt solution that provides nutrients and growth factors essential for the cultivation of a variety of cell types, including adherent and suspension cells. The medium is formulated to support the proliferation and maintenance of cells in vitro.
Sourced in United States, United Kingdom, Germany, China, Canada, France, Italy, Japan, Israel, Switzerland, Australia, Macao, Belgium, Spain, Denmark, Jersey
EGF is a lab equipment product from Thermo Fisher Scientific. It is a recombinant human Epidermal Growth Factor (EGF) protein. EGF is a growth factor that plays a role in cell proliferation and differentiation.
Sourced in United States, United Kingdom, Germany, France, China, Canada, Italy, Switzerland, Macao, Japan, Israel, Australia, Belgium
Insulin is a laboratory product used for the analysis and measurement of insulin levels in biological samples. It is a peptide hormone that plays a crucial role in regulating blood glucose levels. Insulin is commonly used in various research and diagnostic applications within the life sciences and healthcare industries.
Sourced in United States, Germany, United Kingdom, Italy, France, China, Canada, Macao, Sao Tome and Principe, Australia, Israel, Switzerland, Spain, Japan
Cholera toxin is a bacterial protein produced by the bacterium Vibrio cholerae. It has a well-documented function as a potent activator of the adenylate cyclase enzyme, leading to increased levels of cyclic AMP (cAMP) in target cells. This property makes cholera toxin a valuable tool in various areas of biological research, such as cell signaling studies and the investigation of cellular regulatory mechanisms.

More about "Insulin"

Insulin is a vital peptide hormone produced by the pancreatic beta cells that plays a crucial role in regulating blood sugar (glucose) levels.
It facilitates the absorption of glucose by cells, promoting its storage as glycogen and fat.
Insulin also influences protein and lipid (fat) metabolism.
Disruptions in insulin production or signaling can lead to conditions like diabetes mellitus, a common metabolic disorder characterized by high blood sugar levels.
Researchers utilize a variety of insulin-related products and procedures, such as FBS (Fetal Bovine Serum), dexamethasone, hydrocortisone, and penicillin/streptomycin, to investigate the underlying mechanisms and potential therapies for insulin-related disorders.
The culture media DMEM and DMEM/F12 are often used in insulin-related research, while growth factors like EGF (Epidermal Growth Factor) and cholera toxin may be incorporated to support cell growth and differentiation.
PubCompare.ai can help optimize your insulin research by locating the best protocols from literature, pre-prints, and patents, enhancing reproducibility and accuracy to ensure you find the most effective insulin-related products and procedures.
Explore PubCompare.ai today and take your insulin research to the next level.